Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypofibrinolysis is a risk factor for arterial thrombosis at young age.
Guimarães AH, de Bruijne EL, Lisman T, Dippel DW, Deckers JW, Poldermans D, Rijken DC, Leebeek FW. Guimarães AH, et al. Among authors: leebeek fw. Br J Haematol. 2009 Apr;145(1):115-20. doi: 10.1111/j.1365-2141.2008.07568.x. Epub 2009 Jan 30. Br J Haematol. 2009. PMID: 19183334 Free article.
Diagnosis and management of haemophilia.
Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Fijnvandraat K, et al. Among authors: leebeek fw. BMJ. 2012 May 2;344:e2707. doi: 10.1136/bmj.e2707. BMJ. 2012. PMID: 22551712 Free article. Review. No abstract available.
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
de Wee EM, Sanders YV, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin ME, Eikenboom J, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Hamulyák K, Nijziel MR, Fijnvandraat K, Leebeek FW; WiN study group. de Wee EM, et al. Among authors: leebeek fw. Thromb Haemost. 2012 Oct;108(4):683-92. doi: 10.1160/TH12-04-0244. Epub 2012 Aug 23. Thromb Haemost. 2012. PMID: 22918553
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.
Eckhardt CL, van Velzen AS, Peters M, Astermark J, Brons PP, Castaman G, Cnossen MH, Dors N, Escuriola-Ettingshausen C, Hamulyak K, Hart DP, Hay CR, Haya S, van Heerde WL, Hermans C, Holmström M, Jimenez-Yuste V, Keenan RD, Klamroth R, Laros-van Gorkom BA, Leebeek FW, Liesner R, Mäkipernaa A, Male C, Mauser-Bunschoten E, Mazzucconi MG, McRae S, Meijer K, Mitchell M, Morfini M, Nijziel M, Oldenburg J, Peerlinck K, Petrini P, Platokouki H, Reitter-Pfoertner SE, Santagostino E, Schinco P, Smiers FJ, Siegmund B, Tagliaferri A, Yee TT, Kamphuisen PW, van der Bom JG, Fijnvandraat K; INSIGHT Study Group. Eckhardt CL, et al. Among authors: leebeek fw. Blood. 2013 Sep 12;122(11):1954-62. doi: 10.1182/blood-2013-02-483263. Epub 2013 Aug 7. Blood. 2013. PMID: 23926300 Free article.
[Von Willebrand disease in the Netherlands: the WiN study].
Sanders YV, de Wee EM, Meijer K, Eikenboom J, van der Bom JG, Fijnvandraat CJ, Laros-van Gorkom BA, Cnossen MH, Mauser-Bunschoten EP, Leebeek FW. Sanders YV, et al. Among authors: leebeek fw. Ned Tijdschr Geneeskd. 2014;158:A6518. Ned Tijdschr Geneeskd. 2014. PMID: 24800796 Review. Dutch.
[Haemophilia].
Loomans JI, Lock J, Peters M, Leebeek FW, Cnossen MH, Fijnvandraat K. Loomans JI, et al. Among authors: leebeek fw. Ned Tijdschr Geneeskd. 2014;158:A7357. Ned Tijdschr Geneeskd. 2014. PMID: 25351381 Review. Dutch.
von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.
Sanders YV, Groeneveld D, Meijer K, Fijnvandraat K, Cnossen MH, van der Bom JG, Coppens M, de Meris J, Laros-van Gorkom BA, Mauser-Bunschoten EP, Leebeek FW, Eikenboom J; WiN study group. Sanders YV, et al. Among authors: leebeek fw. Blood. 2015 May 7;125(19):3006-13. doi: 10.1182/blood-2014-09-603241. Epub 2015 Feb 11. Blood. 2015. PMID: 25673639 Free article.
Inhibitor development and mortality in non-severe hemophilia A.
Eckhardt CL, Loomans JI, van Velzen AS, Peters M, Mauser-Bunschoten EP, Schwaab R, Mazzucconi MG, Tagliaferri A, Siegmund B, Reitter-Pfoertner SE, van der Bom JG, Fijnvandraat K; INSIGHT Study Group. Eckhardt CL, et al. J Thromb Haemost. 2015 Jul;13(7):1217-25. doi: 10.1111/jth.12990. Epub 2015 Jun 10. J Thromb Haemost. 2015. PMID: 25912309 Free article.
The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia A.
Hazendonk HC, van Moort I, Fijnvandraat K, Kruip MJ, Laros-van Gorkom BA, van der Meer FJ, Meijer K, Peters M, Schutgens RE, Zwaan CM, Driessens MH, Polinder S, Leebeek FW, Mathôt RA, Cnossen MH. Hazendonk HC, et al. Among authors: leebeek fw. Thromb Haemost. 2015 Aug 31;114(3):639-44. doi: 10.1160/TH14-11-0925. Epub 2015 Jun 11. Thromb Haemost. 2015. PMID: 26062822 Clinical Trial.
423 results